Earnings Feed
Start Free
Home/Filings/4/0001855763-24-000009
4//SEC Filing

TURKEL CATHERINE C. 4

Accession 0001855763-24-000009

CIK 0001348362other
View on SEC.govCompany Profile

Filed

May 9, 8:00 PM ET

Accepted

May 10, 5:16 PM ET

Size

9.4 KB

Accession

0001855763-24-000009

Insider Transaction Report

Form 4
Period: 2024-04-26
Lexaria Bioscience Corp.LEXX
TURKEL CATHERINE C.
Director
Transactions
  • Award

    Stock Options

    2024-04-26+5,000→ 15,000 total
    Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (5,000 underlying)
Holdings

  • Stock Options

    Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (1,600 underlying)
    5,000

  • common shares

    1,500

  • Stock Options

    Exercise: $3.04From: 2022-09-02Exp: 2027-09-02→ Common Shares (3,400 underlying)
    3,400

  • Stock Options

    Exercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying)
    10,000

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001705278

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:16 PM ET
Size
9.4 KB
View on SEC.gov